LEADER 01032nam0-22003011i-450- 001 990008105820403321 005 20050505114450.0 010 $a88-8233-312-4 035 $a000810582 035 $aFED01000810582 035 $a(Aleph)000810582FED01 035 $a000810582 100 $a20050505d2003----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $a--------001yy 200 1 $a<>valutazione delle azienda$emetodi tradizionali: patrimoniale, reddituale, finanziario, misto metodi innovativi: EVA, MVA, REI, REIR, OYPAC, BREAK-UP, opzioni reali metodi diretti e dei multipli metodi empirici: di mercato, aziendali, fiscali regole del pollice casi di valutazione$fDaniele Balducci 205 $a7.ed. 210 $aMilano$cFag$d2003 215 $a704 p.$d24 cm 700 1$aBalducci,$bDaniele$0279469 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990008105820403321 952 $aG-64-TB$b8739$fECA 959 $aECA 996 $aValutazione delle azienda$9757556 997 $aUNINA LEADER 03195nam 2200661 a 450 001 996206954403316 005 20230316162028.0 010 $a1-280-78401-6 010 $a9786613694409 010 $a0-470-72077-8 010 $a0-470-71847-1 035 $a(CKB)1000000000688150 035 $a(EBL)703916 035 $a(OCoLC)797918501 035 $a(SSID)ssj0000715495 035 $a(PQKBManifestationID)11956101 035 $a(PQKBTitleCode)TC0000715495 035 $a(PQKBWorkID)10700628 035 $a(PQKB)10410767 035 $a(MiAaPQ)EBC703916 035 $a(Au-PeEL)EBL703916 035 $a(CaPaEBR)ebr10575632 035 $a(CaONFJC)MIL369440 035 $a(EXLCZ)991000000000688150 100 $a19830429d1983 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aFetal antigens and cancer /$f[editors: David Evered (organizer) and Julie Whelan] 210 $aLondon $cPitman ;$aSummit, N.J. $cdistributed in North America by CIBA Pharmaceutical$d1983 215 $a1 online resource (274 pages) $cillustrations 225 1 $aCiba Foundation symposium ;$v96 300 $a"Symposium on Fetal antigens and cancer, held at the Ciba Foundation, London, 20-22 July 1982"--Contents page. 311 0 $a0-470-66414-2 311 0 $a0-272-79660-3 320 $aIncludes bibliographical references and indexes. 327 $aFetal antigens and cancer; Contents; Introduction; Expression of embryonic characters by malignant cells; Discussion; Embryonic antigens in malignancy and pregnancy: common denominators in immune regulation; Discussion; The T/t-complex: a family of genes controlling early embryonic surface antigens; Discussion; Fetal histocompatibility antigens and maternal immune responses; Discussion; How are tumour antigens related to normal antigens?; Discussion; The functional significance of tumour-associated cell surface alterations of embryonic and unknown origin; Discussion 327 $aHost recognition of antigens: do they induce specific antibodies? Discussion; Human chorionic gonadotropin as a model for a fetal antigen; Discussion; Can fetal antigens be used for prophylactic immunization?; Discussion; Parity and susceptibility to cancer; Discussion; Embryonic precancerous and cancerous human antigens recognized by monoclonal antibodies; Discussion; Antibodies to fetal antigens associated with rodent tumours; Discussion; General discussion; Closing remarks; Index of contributors; Subject index 410 0$aCiba Foundation symposium ;$v96. 606 $aFetus$xCancer$vCongresses 606 $aCancer$xImmunological aspects$vCongresses 606 $aTumor antigens$vCongresses 615 0$aFetus$xCancer 615 0$aCancer$xImmunological aspects 615 0$aTumor antigens 676 $a616.99/40792 676 $a616.9940792 701 $aEvered$b David$0857127 701 $aWhelan$b Julie$0322651 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a996206954403316 996 $aFetal antigens and cancer$92179117 997 $aUNISA